Literature DB >> 8380010

Aseptic meningitis as complication of intravenous immunoglobulin therapy for myasthenia gravis.

Z Meiner, T Ben-Hur, Y River, A Reches.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8380010      PMCID： PMC1015071          DOI： 10.1136/jnnp.56.7.830-a

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  7 in total

1.  Aseptic meningitis associated with high dose intravenous immunoglobulin therapy.

Authors:  J D Watson; J Gibson; D E Joshua; H Kronenberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-03       Impact factor: 10.154

2.  Intravenous immune globulin and acute aseptic meningitis.

Authors:  M Casteels-Van Daele; L Wijndaele; K Hanninck; P Gillis
Journal:  N Engl J Med       Date:  1990-08-30       Impact factor: 91.245

3.  Administration of immune globulin associated with aseptic meningitis.

Authors:  E Kato; S Shindo; Y Eto; N Hashimoto; M Yamamoto; Y Sakata; Y Hiyoshi
Journal:  JAMA       Date:  1988-06-10       Impact factor: 56.272

Review 4.  Trimethoprim-sulfamethoxazole-associated aseptic meningitis: case reports and review of the literature.

Authors:  A M Joffe; J D Farley; D Linden; G Goldsand
Journal:  Am J Med       Date:  1989-09       Impact factor: 4.965

5.  Clinical trials of sulfonated immunoglobulin preparation for intravenous administration. II. Adverse reactions.

Authors:  S Matsumoto; N Kobayashi; N Gohya
Journal:  Eur J Pediatr       Date:  1981-05       Impact factor: 3.183

Review 6.  Clinical uses of intravenous immunoglobulins.

Authors:  S A Berkman; M L Lee; R P Gale
Journal:  Ann Intern Med       Date:  1990-02-15       Impact factor: 25.391

Review 7.  Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients.

Authors:  K E Osserman; G Genkins
Journal:  Mt Sinai J Med       Date:  1971 Nov-Dec
  7 in total
  5 in total

Review 1.  Drug-induced aseptic meningitis: diagnosis and management.

Authors:  S Jolles; W A Sewell; C Leighton
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

Review 2.  Experience with intravenous immunoglobulin in myasthenia gravis: a review.

Authors:  G Edan; F Landgraf
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

3.  Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease.

Authors:  Yasushi Kemmotsu; Tomotaka Nakayama; Hiroyuki Matsuura; Tsutomu Saji
Journal:  Pediatr Rheumatol Online J       Date:  2011-09-14       Impact factor: 3.054

Review 4.  Aseptic Meningitis in Oral Medicine: Exploring the Key Elements for a Challenging Diagnosis: A Review of the Literature and Two Case Reports.

Authors:  Stefania Leuci; Noemi Coppola; Tiziana Cantile; Elena Calabria; Laurenta Lelia Mihai; Michele Davide Mignogna
Journal:  Int J Environ Res Public Health       Date:  2022-03-25       Impact factor: 3.390

Review 5.  Current Treatment of Myasthenia Gravis.

Authors:  Mohammed K Alhaidar; Sumayyah Abumurad; Betty Soliven; Kourosh Rezania
Journal:  J Clin Med       Date:  2022-03-14       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.